IL13 and conjunctivitis: Dupilumab (an IL-4 and IL-13 pathway inhibitor) has not been studied in AC, but one reported adverse effect of the drug is conjunctivitis, described as inflammation of the anterior conjunctiva and hyperemia of the limbus [96].